aluates Reports

$ 0.0

Automative

Global Marine Biopharmaceutical Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-2C6281

Global Marine Biopharmaceutical Market Insights and Forecast to 2028

BUY CHAPTERS

Global Marine Biopharmaceutical Market Research Report 2025

Code: QYRE-Auto-2C6281

Report

July 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Seattle Genetics

DSM

Eisai Co Ltd

Takeda

BASF AG

Amway

Pfizer Inc

Pelagia (EPAX)

Pharma Mar SA

CRODA

GNC

GSK

TerSera Therapeutics

Nordic Naturals

Carlson Labs

Marine Biopharmaceutical Market Size

The global market for Marine Biopharmaceutical was valued at US$ 950 million in the year 2024 and is projected to reach a revised size of US$ 1212 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Marine Biopharmaceutical Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Marine Biopharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marine Biopharmaceutical.

The Marine Biopharmaceutical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Marine Biopharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Marine Biopharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Marine Biopharmaceutical Market Report

Report Metric	Details
Report Name	Marine Biopharmaceutical Market
Accounted market size in year	US$ 950 million
Forecasted market size in 2031	US$ 1212 million
CAGR	3.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Drugs Health Supplement
Segment by Application	Hospital & Clinic Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Seattle Genetics, DSM, Eisai Co, Takeda, BASF, Amway, Pfizer, Pelagia (EPAX), Pharma Mar SA, Croda, GNC, GSK, TerSera Therapeutics, Nordic Naturals, Carlson Labs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Marine Biopharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Marine Biopharmaceutical Market growing?

Ans: The Marine Biopharmaceutical Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Marine Biopharmaceutical Market size in 2031?

Ans: The Marine Biopharmaceutical Market size in 2031 will be US$ 1212 million.

Who are the main players in the Marine Biopharmaceutical Market report?

Ans: The main players in the Marine Biopharmaceutical Market are Seattle Genetics, DSM, Eisai Co, Takeda, BASF, Amway, Pfizer, Pelagia (EPAX), Pharma Mar SA, Croda, GNC, GSK, TerSera Therapeutics, Nordic Naturals, Carlson Labs

What are the Application segmentation covered in the Marine Biopharmaceutical Market report?

Ans: The Applications covered in the Marine Biopharmaceutical Market report are Hospital & Clinic, Pharmacy, Other

What are the Type segmentation covered in the Marine Biopharmaceutical Market report?

Ans: The Types covered in the Marine Biopharmaceutical Market report are Drugs, Health Supplement

Recommended Reports

Biopharmaceutical Markets

Oncology & Therapeutics

Process & Technology

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Marine Biopharmaceutical Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Drugs

1.2.3 Health Supplement

1.3 Market by Application

1.3.1 Global Marine Biopharmaceutical Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital & Clinic

1.3.3 Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Marine Biopharmaceutical Market Perspective (2020-2031)

2.2 Global Marine Biopharmaceutical Growth Trends by Region

2.2.1 Global Marine Biopharmaceutical Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Marine Biopharmaceutical Historic Market Size by Region (2020-2025)

2.2.3 Marine Biopharmaceutical Forecasted Market Size by Region (2026-2031)

2.3 Marine Biopharmaceutical Market Dynamics

2.3.1 Marine Biopharmaceutical Industry Trends

2.3.2 Marine Biopharmaceutical Market Drivers

2.3.3 Marine Biopharmaceutical Market Challenges

2.3.4 Marine Biopharmaceutical Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Marine Biopharmaceutical Players by Revenue

3.1.1 Global Top Marine Biopharmaceutical Players by Revenue (2020-2025)

3.1.2 Global Marine Biopharmaceutical Revenue Market Share by Players (2020-2025)

3.2 Global Marine Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Marine Biopharmaceutical Revenue

3.4 Global Marine Biopharmaceutical Market Concentration Ratio

3.4.1 Global Marine Biopharmaceutical Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Marine Biopharmaceutical Revenue in 2024

3.5 Global Key Players of Marine Biopharmaceutical Head office and Area Served

3.6 Global Key Players of Marine Biopharmaceutical, Product and Application

3.7 Global Key Players of Marine Biopharmaceutical, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Marine Biopharmaceutical Breakdown Data by Type

4.1 Global Marine Biopharmaceutical Historic Market Size by Type (2020-2025)

4.2 Global Marine Biopharmaceutical Forecasted Market Size by Type (2026-2031)

5 Marine Biopharmaceutical Breakdown Data by Application

5.1 Global Marine Biopharmaceutical Historic Market Size by Application (2020-2025)

5.2 Global Marine Biopharmaceutical Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Marine Biopharmaceutical Market Size (2020-2031)

6.2 North America Marine Biopharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Marine Biopharmaceutical Market Size by Country (2020-2025)

6.4 North America Marine Biopharmaceutical Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Marine Biopharmaceutical Market Size (2020-2031)

7.2 Europe Marine Biopharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Marine Biopharmaceutical Market Size by Country (2020-2025)

7.4 Europe Marine Biopharmaceutical Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Marine Biopharmaceutical Market Size (2020-2031)

8.2 Asia-Pacific Marine Biopharmaceutical Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Marine Biopharmaceutical Market Size by Region (2020-2025)

8.4 Asia-Pacific Marine Biopharmaceutical Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Marine Biopharmaceutical Market Size (2020-2031)

9.2 Latin America Marine Biopharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Marine Biopharmaceutical Market Size by Country (2020-2025)

9.4 Latin America Marine Biopharmaceutical Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Marine Biopharmaceutical Market Size (2020-2031)

10.2 Middle East & Africa Marine Biopharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Marine Biopharmaceutical Market Size by Country (2020-2025)

10.4 Middle East & Africa Marine Biopharmaceutical Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Seattle Genetics

11.1.1 Seattle Genetics Company Details

11.1.2 Seattle Genetics Business Overview

11.1.3 Seattle Genetics Marine Biopharmaceutical Introduction

11.1.4 Seattle Genetics Revenue in Marine Biopharmaceutical Business (2020-2025)

11.1.5 Seattle Genetics Recent Development

11.2 DSM

11.2.1 DSM Company Details

11.2.2 DSM Business Overview

11.2.3 DSM Marine Biopharmaceutical Introduction

11.2.4 DSM Revenue in Marine Biopharmaceutical Business (2020-2025)

11.2.5 DSM Recent Development

11.3 Eisai Co

11.3.1 Eisai Co Company Details

11.3.2 Eisai Co Business Overview

11.3.3 Eisai Co Marine Biopharmaceutical Introduction

11.3.4 Eisai Co Revenue in Marine Biopharmaceutical Business (2020-2025)

11.3.5 Eisai Co Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Marine Biopharmaceutical Introduction

11.4.4 Takeda Revenue in Marine Biopharmaceutical Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 BASF

11.5.1 BASF Company Details

11.5.2 BASF Business Overview

11.5.3 BASF Marine Biopharmaceutical Introduction

11.5.4 BASF Revenue in Marine Biopharmaceutical Business (2020-2025)

11.5.5 BASF Recent Development

11.6 Amway

11.6.1 Amway Company Details

11.6.2 Amway Business Overview

11.6.3 Amway Marine Biopharmaceutical Introduction

11.6.4 Amway Revenue in Marine Biopharmaceutical Business (2020-2025)

11.6.5 Amway Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Marine Biopharmaceutical Introduction

11.7.4 Pfizer Revenue in Marine Biopharmaceutical Business (2020-2025)

11.7.5 Pfizer Recent Development

11.8 Pelagia (EPAX)

11.8.1 Pelagia (EPAX) Company Details

11.8.2 Pelagia (EPAX) Business Overview

11.8.3 Pelagia (EPAX) Marine Biopharmaceutical Introduction

11.8.4 Pelagia (EPAX) Revenue in Marine Biopharmaceutical Business (2020-2025)

11.8.5 Pelagia (EPAX) Recent Development

11.9 Pharma Mar SA

11.9.1 Pharma Mar SA Company Details

11.9.2 Pharma Mar SA Business Overview

11.9.3 Pharma Mar SA Marine Biopharmaceutical Introduction

11.9.4 Pharma Mar SA Revenue in Marine Biopharmaceutical Business (2020-2025)

11.9.5 Pharma Mar SA Recent Development

11.10 Croda

11.10.1 Croda Company Details

11.10.2 Croda Business Overview

11.10.3 Croda Marine Biopharmaceutical Introduction

11.10.4 Croda Revenue in Marine Biopharmaceutical Business (2020-2025)

11.10.5 Croda Recent Development

11.11 GNC

11.11.1 GNC Company Details

11.11.2 GNC Business Overview

11.11.3 GNC Marine Biopharmaceutical Introduction

11.11.4 GNC Revenue in Marine Biopharmaceutical Business (2020-2025)

11.11.5 GNC Recent Development

11.12 GSK

11.12.1 GSK Company Details

11.12.2 GSK Business Overview

11.12.3 GSK Marine Biopharmaceutical Introduction

11.12.4 GSK Revenue in Marine Biopharmaceutical Business (2020-2025)

11.12.5 GSK Recent Development

11.13 TerSera Therapeutics

11.13.1 TerSera Therapeutics Company Details

11.13.2 TerSera Therapeutics Business Overview

11.13.3 TerSera Therapeutics Marine Biopharmaceutical Introduction

11.13.4 TerSera Therapeutics Revenue in Marine Biopharmaceutical Business (2020-2025)

11.13.5 TerSera Therapeutics Recent Development

11.14 Nordic Naturals

11.14.1 Nordic Naturals Company Details

11.14.2 Nordic Naturals Business Overview

11.14.3 Nordic Naturals Marine Biopharmaceutical Introduction

11.14.4 Nordic Naturals Revenue in Marine Biopharmaceutical Business (2020-2025)

11.14.5 Nordic Naturals Recent Development

11.15 Carlson Labs

11.15.1 Carlson Labs Company Details

11.15.2 Carlson Labs Business Overview

11.15.3 Carlson Labs Marine Biopharmaceutical Introduction

11.15.4 Carlson Labs Revenue in Marine Biopharmaceutical Business (2020-2025)

11.15.5 Carlson Labs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Seattle Genetics

DSM

Eisai Co Ltd

Takeda

BASF AG

Amway

Pfizer Inc

Pelagia (EPAX)

Pharma Mar SA

CRODA

GNC

GSK

TerSera Therapeutics

Nordic Naturals

Carlson Labs

List of Tables

Table 1. Global Marine Biopharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Drugs

Table 3. Key Players of Health Supplement

Table 4. Global Marine Biopharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Marine Biopharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Marine Biopharmaceutical Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Marine Biopharmaceutical Market Share by Region (2020-2025)

Table 8. Global Marine Biopharmaceutical Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Marine Biopharmaceutical Market Share by Region (2026-2031)

Table 10. Marine Biopharmaceutical Market Trends

Table 11. Marine Biopharmaceutical Market Drivers

Table 12. Marine Biopharmaceutical Market Challenges

Table 13. Marine Biopharmaceutical Market Restraints

Table 14. Global Marine Biopharmaceutical Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Marine Biopharmaceutical Market Share by Players (2020-2025)

Table 16. Global Top Marine Biopharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Biopharmaceutical as of 2024)

Table 17. Ranking of Global Top Marine Biopharmaceutical Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Marine Biopharmaceutical Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Marine Biopharmaceutical, Headquarters and Area Served

Table 20. Global Key Players of Marine Biopharmaceutical, Product and Application

Table 21. Global Key Players of Marine Biopharmaceutical, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Marine Biopharmaceutical Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Marine Biopharmaceutical Revenue Market Share by Type (2020-2025)

Table 25. Global Marine Biopharmaceutical Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Marine Biopharmaceutical Revenue Market Share by Type (2026-2031)

Table 27. Global Marine Biopharmaceutical Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Marine Biopharmaceutical Revenue Market Share by Application (2020-2025)

Table 29. Global Marine Biopharmaceutical Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Marine Biopharmaceutical Revenue Market Share by Application (2026-2031)

Table 31. North America Marine Biopharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Marine Biopharmaceutical Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Marine Biopharmaceutical Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Marine Biopharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Marine Biopharmaceutical Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Marine Biopharmaceutical Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Marine Biopharmaceutical Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Marine Biopharmaceutical Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Marine Biopharmaceutical Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Marine Biopharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Marine Biopharmaceutical Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Marine Biopharmaceutical Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Marine Biopharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Marine Biopharmaceutical Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Marine Biopharmaceutical Market Size by Country (2026-2031) & (US$ Million)

Table 46. Seattle Genetics Company Details

Table 47. Seattle Genetics Business Overview

Table 48. Seattle Genetics Marine Biopharmaceutical Product

Table 49. Seattle Genetics Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 50. Seattle Genetics Recent Development

Table 51. DSM Company Details

Table 52. DSM Business Overview

Table 53. DSM Marine Biopharmaceutical Product

Table 54. DSM Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 55. DSM Recent Development

Table 56. Eisai Co Company Details

Table 57. Eisai Co Business Overview

Table 58. Eisai Co Marine Biopharmaceutical Product

Table 59. Eisai Co Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 60. Eisai Co Recent Development

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda Marine Biopharmaceutical Product

Table 64. Takeda Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. BASF Company Details

Table 67. BASF Business Overview

Table 68. BASF Marine Biopharmaceutical Product

Table 69. BASF Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 70. BASF Recent Development

Table 71. Amway Company Details

Table 72. Amway Business Overview

Table 73. Amway Marine Biopharmaceutical Product

Table 74. Amway Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 75. Amway Recent Development

Table 76. Pfizer Company Details

Table 77. Pfizer Business Overview

Table 78. Pfizer Marine Biopharmaceutical Product

Table 79. Pfizer Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 80. Pfizer Recent Development

Table 81. Pelagia (EPAX) Company Details

Table 82. Pelagia (EPAX) Business Overview

Table 83. Pelagia (EPAX) Marine Biopharmaceutical Product

Table 84. Pelagia (EPAX) Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 85. Pelagia (EPAX) Recent Development

Table 86. Pharma Mar SA Company Details

Table 87. Pharma Mar SA Business Overview

Table 88. Pharma Mar SA Marine Biopharmaceutical Product

Table 89. Pharma Mar SA Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 90. Pharma Mar SA Recent Development

Table 91. Croda Company Details

Table 92. Croda Business Overview

Table 93. Croda Marine Biopharmaceutical Product

Table 94. Croda Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 95. Croda Recent Development

Table 96. GNC Company Details

Table 97. GNC Business Overview

Table 98. GNC Marine Biopharmaceutical Product

Table 99. GNC Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 100. GNC Recent Development

Table 101. GSK Company Details

Table 102. GSK Business Overview

Table 103. GSK Marine Biopharmaceutical Product

Table 104. GSK Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 105. GSK Recent Development

Table 106. TerSera Therapeutics Company Details

Table 107. TerSera Therapeutics Business Overview

Table 108. TerSera Therapeutics Marine Biopharmaceutical Product

Table 109. TerSera Therapeutics Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 110. TerSera Therapeutics Recent Development

Table 111. Nordic Naturals Company Details

Table 112. Nordic Naturals Business Overview

Table 113. Nordic Naturals Marine Biopharmaceutical Product

Table 114. Nordic Naturals Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 115. Nordic Naturals Recent Development

Table 116. Carlson Labs Company Details

Table 117. Carlson Labs Business Overview

Table 118. Carlson Labs Marine Biopharmaceutical Product

Table 119. Carlson Labs Revenue in Marine Biopharmaceutical Business (2020-2025) & (US$ Million)

Table 120. Carlson Labs Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Marine Biopharmaceutical Picture

Figure 2. Global Marine Biopharmaceutical Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Marine Biopharmaceutical Market Share by Type: 2024 VS 2031

Figure 4. Drugs Features

Figure 5. Health Supplement Features

Figure 6. Global Marine Biopharmaceutical Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Marine Biopharmaceutical Market Share by Application: 2024 VS 2031

Figure 8. Hospital & Clinic Case Studies

Figure 9. Pharmacy Case Studies

Figure 10. Other Case Studies

Figure 11. Marine Biopharmaceutical Report Years Considered

Figure 12. Global Marine Biopharmaceutical Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Marine Biopharmaceutical Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Marine Biopharmaceutical Market Share by Region: 2024 VS 2031

Figure 15. Global Marine Biopharmaceutical Market Share by Players in 2024

Figure 16. Global Top Marine Biopharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Biopharmaceutical as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Marine Biopharmaceutical Revenue in 2024

Figure 18. North America Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Marine Biopharmaceutical Market Share by Country (2020-2031)

Figure 20. United States Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Marine Biopharmaceutical Market Share by Country (2020-2031)

Figure 24. Germany Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Marine Biopharmaceutical Market Share by Region (2020-2031)

Figure 32. China Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Marine Biopharmaceutical Market Share by Country (2020-2031)

Figure 40. Mexico Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Marine Biopharmaceutical Market Share by Country (2020-2031)

Figure 44. Turkey Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Marine Biopharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Seattle Genetics Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 48. DSM Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 49. Eisai Co Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 50. Takeda Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 51. BASF Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 52. Amway Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 53. Pfizer Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 54. Pelagia (EPAX) Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 55. Pharma Mar SA Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 56. Croda Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 57. GNC Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 58. GSK Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 59. TerSera Therapeutics Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 60. Nordic Naturals Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 61. Carlson Labs Revenue Growth Rate in Marine Biopharmaceutical Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Aquaculture Bacterial Diagnosis Market Research Report 2025

Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Asset Managements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Biopharmaceutical Biopharma Autoclaves Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global BioPharma Service Market Research Report 2024

Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Microbial Fermentation Technology for Bio Pharmaceutical Industries Market

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Liquid Handling Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions